Beijing Anzhen Hospital: clinical-trial pipeline
Beijing Anzhen Hospital is the sponsor of 189 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 99 are not yet finished and 1 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 158 |
| Phase 4 | 20 |
| Phase 3 | 6 |
| Phase 2/3 | 3 |
| Phase 2 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 68 |
| Recruiting | 46 |
| Not yet recruiting | 45 |
| Completed | 22 |
| Active, not recruiting | 8 |
Condition areas
| Area | Trials |
|---|---|
| Cardiovascular | 155 |
| Rare and genetic diseases | 20 |
| Neurology | 8 |
| Respiratory | 8 |
| Metabolic and endocrine (diabetes, obesity) | 6 |
| Nephrology and urology | 5 |
| Gastroenterology and liver | 2 |
| Immunology and rheumatology | 1 |
| Infectious disease and vaccines | 1 |
| Musculoskeletal | 1 |
| Oncology | 1 |
| Psychiatry and mental health | 1 |
Countries
| Country | Trials |
|---|---|
| China | 155 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-09-15 | New trial posted | Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07511231 | Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI | Not applicable | Not yet recruiting | China |
| NCT07377422 | Safety and Efficacy of a Novel Composite-Tip Guiding Catheter in Transcarotid Artery Stenting Via Transradial… | Not applicable | Recruiting | China |
| NCT07256197 | PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis | Phase 3 | Not yet recruiting | China |
| NCT06663566 | Application of FAPI Visualization in the Assessment of Right Ventricular Dysfunction Due to Volume Overload | Not applicable | Recruiting | China |
| NCT07316270 | SAfety and eFfectiveness of cathetER Ablation for Atrial Fibrillation With Intracranial Hemorrhage (SAFER-AF) | Not applicable | Recruiting | China |
| NCT06274411 | Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention | Not applicable | Recruiting | China |
| NCT06987825 | Chinese Atrial Fibrillation Registry | Not applicable | Recruiting | China |
| NCT06791629 | Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation | Not applicable | Not yet recruiting | China |
| NCT07372729 | Smartwatch-based Intervention for Cardiovascular Health (SWITCH) | Not applicable | Recruiting | China |
| NCT07023237 | 3D-Guided Pulsed Field Ablation for Paroxysmal AF | Not applicable | Not yet recruiting | |
| NCT06871228 | Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fib… | Not applicable | Recruiting | China |
| NCT07605624 | Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease | Not applicable | Not yet recruiting | China |
| NCT07619222 | Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Patients With Differe… | Not applicable | Not yet recruiting | |
| NCT06796127 | A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease | Not applicable | Not yet recruiting | China |
| NCT06927908 | Cardiac Denervation in Aortic Arch Replacement | Not applicable | Not yet recruiting | |
| NCT06907238 | The Value of Novel Thrombus Markers in the Diagnosis and Treatment of Acute Pulmonary Embolism | Not applicable | Active, not recruiting | China |
| NCT07507162 | Timing of Endoscopy in Coronary Heart Disease Patients Taking Antiplatelet Drugs With Acute Non-variceal Uppe… | Not applicable | Not yet recruiting | |
| NCT07621107 | Effect of Guanxinning Tablet on Coronary Microcirculation After Primary Percutaneous Coronary Intervention in… | Phase 2 | Not yet recruiting | |
| NCT07149688 | Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQU… | Not applicable | Recruiting | China |
| NCT07103863 | Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis | Not applicable | Recruiting | China |
| NCT07820410 | Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction | Phase 2/3 | Recruiting | China |
| NCT07626398 | All-Trans Retinoic Acid for the Treatment of Hemophagocytic Lymphohistiocytosis | Phase 2/3 | Not yet recruiting | |
| NCT07264881 | For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed… | Not applicable | Not yet recruiting | China |
| NCT07367399 | Acute Myocardial Infarction Clinical Intelligent Decision Support System | Not applicable | Active, not recruiting | China |
| NCT07466056 | Application of Non-inductive Intelligent Physical Sign Monitoring Equipment Based on Flexible Electronic Devi… | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Beijing Anzhen Hospital clinical trials: 99 open, 9 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/beijing-anzhen-hospital/, data as of 2026-10-25.